Summary
Mechanisms and variations in the food-induced increase in the bioavailability of propranolol were assessed by single-dose (80 mg) studies in healthy volunteers who took the drug on an empty stomach, immediately after a protein-rich breakfast, and together with a carbohydrate-rich, protein-poor breakfast.
Concomitant intake of the protein-rich, but not the carbohydrate-rich, protein-poor breakfast, increased the bioavailability of propranolol in most, but not all, subjects. The food (protein) effect displayed much inter-individual variation, from a decrease to a 250% increase, which could be explained, at least in part, by a correlation between the oral clearance of propranolol and the food-induced increase in its bioavailability.
The food effect was not associated with decreased total availability, but with delayed appearance, of the oxidative metabolites 4-OHP, NLA and PG. Hence the food (protein) effect does not seem to be caused by enzyme inhibition, but rather it is due to reduced hepatic extraction of propranolol, probably consequent to an increased hepatic entry rate.
When taken together with the protein-rich breakfast, propranolol usually appeared in systemic blood at least as early as when taken on an empty stomach, implying that gastric absorption of propranolol may be possible in the presence of protein-rich food. Within the individual the food effect was reproducible, but its magnitude showed an intraindividual variation that may reflect its dependence upon the rates of gastrointestinal absorption and splanchnic-hepatic blood flow, and hence upon the rate of hepatic drug entry.
Similar content being viewed by others
References
Melander A, Danielson K, Scherstén B, W»hlin E (1977) Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther 22: 108–112
MacLean AJ, Isbister C, Bobik A, Dudley F (1981) Reduction of first-pass hepatic clearance of propranolol by food. Clin Pharmacol Ther 30: 91–34
Walle T, Fagan T, Walle KU, Oexmann M-J, Conradi EC, Gaffney TE (1981) Food-induced increase in propranolol bioavailability — relationship to protein and effects on metabolites. Clin Pharmacol Ther 30: 790–795
Liedholm H, Melander A (1986) Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation. Clin Pharmacol Ther 40: 29–36
McLean AJ, McNamara PJ, duSouich P, Gibaldi M, Lalka D (1978) Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism. Clin Pharmacol Ther 24: 5–10
Jackman GP, McLean AJ, Jennings GL, Bobik A (1981) No stereoselective first-pass hepatic extraction of propranolol. Clin Pharmacol Ther 30: 291–296
Olanoff LS, Walle T, Cowart TD, Walle KU, Oexmann MJ, Conradi EC (1986) Food effects on propranolol systemic and oral clearance: Support for a blood flow hypothesis. Clin Pharmacol Ther 40: 408–414
Wagner JD (1985) Propranolol: Pooled Michaelis-Menten parameters and the effect of input rate on bioavailability. Clin Pharmacol Ther 37: 481–487
Byrne AJ, McNeil J, Harrison PM, Louis W, Tonkin AM, McLean AJ (1984) Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions. Br J Clin Pharmacol: 17 [Suppl 1] 45–50
Svensson CK, Cumella JC, Tronolone M, Middleton Jr E, Lalka D (1985) Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow. Clin Pharmacol Ther 37: 464–468
Svensson CK, Edwards DJ, Mauriello PM, Barde SH, Foster AC, Lanc RA, Middleton Jr E, Lalka D (1989) Effect of food on hepatic blood flow: Implications in the “food effect” phenomenon. Clin Pharmacol Ther 34: 316–323
Svensson CK, Mauriello PM, Barde SH, Foster AC, Middleton Jr E, Lalka D (1984) Effect of carbohydrates on estimated hepatic blood flow. Clin Pharmacol Ther 35: 660–665
Woodruff Modi M, Hassett JM, Lalka D (1988) Influence of posture on hepatic perfusion and the presystemic biotransformation of propranolol: Simulation of the food effect. Clin Pharmacol Ther 44: 268–274
Melander A, Stenberg P, Liedholm H, Scherstén B, W»hlin-Boll E (1979) Food-induced reduction in bioavailability of atenolol. Eur J Clin Pharmacol 16: 327–330
Axelson JE, Chan GLY, Kirsten EB, Mason WD, Lanman EC, Kerr CE (1987) Enhancement of the bioavailability of propafenone by food. Br J Clin Pharmacol 23: 735–741
Wald A, Van Thiel DH, Hoechstetter L, Gavaler JS, Egler KM, Verm R, Scott L, Lester R (1981) Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 80: 1497–1500
Walle T, Walle UK, Knapp DR, Conradi EC, Berger EM (1983) Identification of major sulfate conjugates in the metabolism of propranolol in dog and man. Drug Metab Dispos 11: 344–349
Harrison PM, Tonkin AM, Cahill CM, McLean AJ (1985) The rapid and simultaneous extraction of propranolol, its neutral and basic metabolites from plasma and assay by high performance liquid chromatography. J Chromatogr 343: 349–358
Pritchard JF, Schneck DW, Hayes Jr AH (1979) Determinations of propranolol and six metabolites in human urine by high-pressure liquid chromatography. J Chromatogr 162: 47–55
Paterson JW, Conolly ME, Dollery CT, Hayes A, Cooper RG (1970) The pharmacodynamics and metabolism of propranolol in man. Pharmacol Clin 2: 127–133
Naranjo CA, Sellers EM, Khouw V (1982) Unaltered serum propranolol binding by meal-induced variations in fatty acids. Br J Clin Pharmacol 13: 575–576
Mojaverian P, Rocci ML Jr, Conner DP, Abrams WB, Vlasses PH (1987) Effect of food on the absorption of entericcoated aspirin: correlation with gastric residence time. Clin Pharmacol Ther 41: 11–7
Rocci ML Jr, Mojaverian P, Davis RJ, Ferguson RK, Vlasses PH (1987) Food-induced gastric retention and absorption of sustained-release procainamide. Clin Pharmacol Ther 42: 45–49
Liedholm H, Lidén A, Kroon L, Melander A, W»hlin-Boll E (1985) Pharmacokinetics of dixyrazine: Low bioavailability, improved by food intake. Drug Nutr Interact 3: 87–92
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liedholm, H., W»hlin-Boll, E. & Melander, A. Mechanisms and variations in the food effect on propranolol bioavailability. Eur J Clin Pharmacol 38, 469–475 (1990). https://doi.org/10.1007/BF02336686
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02336686